Inventor

BOLD GUIDO

CH62 patents

⚠️ This page may combine multiple inventors who share the name “BOLD GUIDO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOLD GUIDO

NOVARTIS AG

Phthalazines with angiogenesis inhibiting activity

Pyrazole derivatives and processes for the preparation thereof

Bicyclic amides as kinase inhibitors

Anthranilic acid amides and the use thereof as medicaments

Pyrrolopyrimidines and processes for the preparation thereof

VEGF receptor tyrosine kinase inhibitors

VEGF receptor tyrosine kinase inhibitors

Pyrimidine derivatives and processes for the preparation thereof

Substituted pyrrolopyrimidines and processes for their preparation

Phthalazines with angiogenesis inhibiting activity

2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors

Isoquinoline derivatives with angiogenesis inhibiting activity

Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity

Pyrrolopyrimidines and processes for their preparation

Antiretroviral hydrazine derivatives

Antiviral ethers of aspartate protease substrate isosteres

Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases

Phthalazine derivatives for treating inflammatory diseases

Pyrirnidinyl aryl urea derivatives being FGF inhibitors

Phthalazine derivatives with angiogenesis inhibiting activity

4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives

Azahexane derivatives as substrate isosters of retroviral asparate proteases

Phthalazine derivatives with angiogenesis inhibiting activity

Phenylacetamides suitable as protein kinase inhibitors

7H-pyrrolo[2,3-d]pyrimidine derivatives

Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase

Cyclic diaryl ureas suitable as tyrosine kinase inhibitors

Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors

Oxazolo-and furopyrimidines and their use in medicaments against tumors

Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors

CIBA GEIGY CORP

Cyclic hydrazine compounds

Antiviral ethers of aspartate protease substrate isosteres

5-amino-4-hydroxyhexanoic acid derivatives

Morpholin- and thiomorpholin-4-ylamides

Unsaturated amino acids

Complexes having optically active ligands, a process for their preparation and their use

Complexes containing optically active sugar ligands, a process for their preparation and their use

Metal complexes containing optically active sugar ligands, a process for their preparation and their use as chiral reactants for synthesis of alcohols and amines

Unsaturated amino acids

Use of compositions for combating tumour diseases

NOVARTIS FINANCE CORP

Antivirally active heterocyclic azahexane derivatives

Antivirally active heterocyclic azahexane derivatives

Antivirally active heterocyclic azahexane derivatives

Combinations of HIV protease inhibitors with reverse transcriptase inhibitors

Intermediates for the preparation of peptide analogues

NOVATIS AG

Epothilone derivatives and their use as antitumor agents

DING QIANG

Compounds and compositions as protein kinase inhibitors

CIBA GEIGY AG

Antiviral ethers of aspartate protease substrate isosteres

SCHERING AG

N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF

BOLD GUIDO

Pyrimidinyl aryl urea derivatives being FGF inhibitors